HuGE Literature Finder
Records
1
-
28
| Nuclear ELAC2 overexpression is associated with increased hazard for relapse after radical prostatectomy. Oncotarget 2019 Aug 10 (48): 4973-4986. Schroeder Cornelia, Navid-Hill Elham, Meiners Jan, Hube-Magg Claudia, Kluth Martina, Makrypidi-Fraune Georgia, Simon Ronald, Büscheck Franziska, Luebke Andreas M, Goebel Cosima, Lang Dagmar S, Weidemann Sören, Neubauer Emily, Hinsch Andrea, Jacobsen Frank, Lebok Patrick, Michl Uwe, Pehrke Dirk, Huland Hartwig, Graefen Markus, Schlomm Thorsten, Sauter Guido, Höflmayer Dor |
| Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk. Urologic oncology 2016 Jun . Alvarez-Cubero Maria Jesus, Pascual-Geler Manrique, Martinez-Gonzalez Luis Javier, Expósito Ruiz Manuela, Saiz Maria, Cozar Jose Manuel, Lorente Jose Anton |
| Prognostic role of genetic biomarkers in clinical progression of prostate cancer. Experimental & molecular medicine 2015 47 e176. Alvarez-Cubero Maria Jesus, Martinez-Gonzalez Luis Javier, Saiz Maria, Carmona-Saez Pedro, Alvarez Juan Carlos, Pascual-Geler Manrique, Lorente Jose Antonio, Cozar Jose Manu |
| ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies. Prostate cancer and prostatic diseases 2010 Sep 13 (3): 270-7. Xu B, Tong N, Li J-m, Zhang Z-d, Wu H |
| Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Feb 19 (2): 588-99. Beuten Joke, Gelfond Jonathan A L, Franke Jennifer L, Shook Stacey, Johnson-Pais Teresa L, Thompson Ian M, Leach Robin |
| Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. The Prostate 2008 Dec 68 (16): 1790-7. Robbins Christiane M, Hernandez Wenndy, Ahaghotu Chiledum, Bennett James, Hoke Gerald, Mason Terry, Pettaway Curtis A, Vijayakumar Srinivasan, Weinrich Sally, Furbert-Harris Paulette, Dunston Georgia, Powell Isaac J, Carpten John D, Kittles Rick |
| Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study. Carcinogenesis 2008 May 29 (5): 999-1004. Chen Yen-Ching, Giovannucci Edward, Kraft Peter, J Hunter Dav |
| Association of hereditary prostate cancer gene polymorphic variants with sporadic aggressive prostate carcinoma. The Prostate 2006 Jan 66 (1): 49-56. Noonan-Wheeler Ferrin C, Wu William, Roehl Kimberly A, Klim Aleksandra, Haugen John, Suarez Brian K, Kibel Adam |
| Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005 Apr 14 (4): 949-57. Rennert Hanna, Zeigler-Johnson Charnita M, Addya Kathakali, Finley Matthew J, Walker Amy H, Spangler Elaine, Leonard Debra G B, Wein Alan, Malkowicz S Bruce, Rebbeck Timothy |
| Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genetic epidemiology 2005 Apr 28 (3): 232-43. Camp Nicola J, Swensen Jeff, Horne Benjamin D, Farnham James M, Thomas Alun, Cannon-Albright Lisa A, Tavtigian Sean |
| Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. British journal of cancer 2005 Mar 92 (6): 1159-64. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, Vogel W, Paiss |
| HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer. The Prostate 2004 Nov 61 (3): 248-52. Yokomizo Akira, Koga Hirofumi, Kinukawa Naoko, Tsukamoto Taiji, Hirao Yoshihiko, Akaza Hideyuki, Mori Mitsuru, Naito Sei |
| Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men. International journal of cancer. Journal international du cancer 2003 Nov 107 (2): 224-8. Takahashi Hiroyuki, Lu Wei, Watanabe Masatoshi, Katoh Takahiko, Furusato Masakuni, Tsukino Hiromasa, Nakao Hiroyuki, Sudo Akemi, Suzuki Hiroyoshi, Akakura Koichiro, Ikemoto Isao, Asano Kouji, Ito Takaaki, Wakui Shin, Muto Tomoko, Hano Hiros |
| Analysis of polymorphic patterns in candidate genes in Israeli patients with prostate cancer. The Israel Medical Association journal : IMAJ 2003 Oct 5 (10): 741-5. Figer Arie, Friedman Tal, Manguoglu Ayse Esra, Flex Dov, Vazina Amnon, Novikov Ilia, Shtrieker Avi, Sidi A Ami, Tichler Thomas, Sapir Einat Even, Baniel Jack, Friedman Eit |
| Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003 Sep 12 (9): 876-81. Stanford Janet L, Sabacan Leah P, Noonan Elizabeth A, Iwasaki Lori, Shu Jianfen, Feng Ziding, Ostrander Elaine |
| ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer. Journal of the National Cancer Institute 2003 Jun 95 (11): 818-24. Severi Gianluca, Giles Graham G, Southey Melissa C, Tesoriero Andrea, Tilley Wayne, Neufing Petra, Morris Howard, English Dallas R, McCredie Margaret R E, Boyle Peter, Hopper John |
| HPC2/ELAC2 gene variants associated with incident prostate cancer. Journal of human genetics 2003 48 (12): 634-8. Adler David, Kanji Nimira, Trpkov Kiril, Fick Gordon, Hughes Rhiannon |
| Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer. Genes, chromosomes & cancer 2003 12 39 (2): 119-25. Nupponen Nina N, Wallén Mika J, Ponciano Damaris, Robbins Christiane M, Tammela Teuvo L J, Vessella Robert L, Carpten John D, Visakorpi Tap |
| Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer. American journal of human genetics 2002 Dec 71 (6): 1475-8. Camp Nicola J, Tavtigian Sean |
| ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago. Human genetics 2002 Oct 111 (4-5): 398-400. Shea Patrick R, Ferrell Robert E, Patrick Alan L, Kuller Lewis H, Bunker Clareann |
| HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease. British journal of cancer 2002 Oct 87 (8): 905-8. Meitz J C, Edwards S M, Easton D F, Murkin A, Ardern-Jones A, Jackson R A, Williams S, Dearnaley D P, Stratton M R, Houlston R S, Eeles R A, |
| Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series. Journal of human genetics 2002 47 (12): 641-8. Fujiwara Hiromichi, Emi Mitsura, Nagai Hisaki, Nishimura Taiji, Konishi Noboru, Kubota Yoshinobu, Ichikawa Tomohiko, Takahashi Satoru, Shuin Taro, Habuchi Tomonori, Ogawa Osamu, Inoue Katsuki, Skolnick Mark H, Swensen Jeff, Camp Nicola J, Tavtigian Sean |
| Role of HPC2/ELAC2 in hereditary prostate cancer. Cancer research 2001 Sep 61 (17): 6494-9. Wang L, McDonnell S K, Elkins D A, Slager S L, Christensen E, Marks A F, Cunningham J M, Peterson B J, Jacobsen S J, Cerhan J R, Blute M L, Schaid D J, Thibodeau S |
| Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. Cancer research 2001 Jul 61 (13): 4982-4. Suarez B K, Gerhard D S, Lin J, Haberer B, Nguyen L, Kesterson N K, Catalona W |
| Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer. American journal of human genetics 2001 Apr 68 (4): 901-11. Xu J, Zheng S L, Carpten J D, Nupponen N N, Robbins C M, Mestre J, Moses T Y, Faith D A, Kelly B D, Isaacs S D, Wiley K E, Ewing C M, Bujnovszky P, Chang B, Bailey-Wilson J, Bleecker E R, Walsh P C, Trent J M, Meyers D A, Isaacs W |
| HPC2 variants and screen-detected prostate cancer. American journal of human genetics 2001 Apr 68 (4): 912-7. Vesprini D, Nam R K, Trachtenberg J, Jewett M A, Tavtigian S V, Emami M, Ho M, Toi A, Narod S |
| Loss of heterozygosity of the putative prostate cancer susceptibility gene HPC2/ELAC2 is uncommon in sporadic and familial prostate cancer. Cancer research 2001 12 61 (24): 8651-3. Wu Y Q, Chen H, Rubin M A, Wojno K J, Cooney K |
| Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population. Anticancer research 0 22 (6B): 3507-11. Suzuki Kazuhiro, Ohtake Nobuaki, Nakata Seiji, Takei Tomoyuki, Matsui Hiroshi, Ono Yoshihiro, Nakazato Haruki, Hasumi Masaru, Koike Hidekazu, Ito Kazuto, Fukabori Yoshitatsu, Kurokawa Kohei, Yamanaka Hidetos |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 03, 2023
- Content source: